Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2020
SIETES contiene 93097 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Walsh S, King E, Brayne C. France removes state funding for dementia drugs. BMJ 2020;367:17 de enero. [Ref.ID 103511]
2.Enlace a cita original Cita con resumen
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:25 de abril. [Ref.ID 102571]
3. Cita con resumen
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 2011;59:111-222. [Ref.ID 90769]
4.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-31. [Ref.ID 90421]
5.Tiene citas relacionadas Cita con resumen
Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S, Solomon AW, Zingeser J, Emerson PM. Effect of three years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet 2006;368:589-95. [Ref.ID 77813]
6. Cita con resumen
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, for Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7. [Ref.ID 75757]
Seleccionar todas
 
 1 a 7 de 7